NCT07194798Not yet recruiting
Drainage Technique in CABG
A Prospective Randomized Trial Comparing the Posterior Pericardial Window Versus Retro-Cardiac Drain for the Prevention of Postoperative Atrial Fibrillation and Pericardial Complications Following CABG
Source: ClinicalTrials.gov · Last updated 26 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
aims to compare the efficacy of the posterior pericardial window versus retro-cardiac drain in preventing postoperative atrial fibrillation and pericardial complications following CABG, while assessing their impact on hospital and ICU stay, pericardial effusions, re exploration for bleeding, post-operative blood transfusions, and mortality.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 122 (estimated)
- First submitted
- 19 Sept 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- Assiut University
- Diseases
- Atrial fibrillation
- NCT number
- NCT07194798
What you commit to
- Study type: Observational
- Planned participants: 122
- From 1 Oct 2025 to the primary completion date, 1 Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients undergoing combined cardiac procedures (e.g., valve repair or replacement).
- Known bleeding disorders or ongoing anticoagulation therapy that cannot be paused.
- Chronic pulmonary disease or pleural pathology that may interfere with drainage assessment.
- Patients with active infections or systemic inflammatory conditions.
Other
- Emergency CABG cases or re-operations.
- Severe pericardial adhesions or anatomical abnormalities preventing safe creation of a posterior pericardial window.
Who the study is looking for
- Adult patients (aged 18 and above) scheduled for elective, first-time coronary artery bypass grafting (CABG).
- Patients with preserved left ventricular function (ejection fraction ≥ 35%).
- Ability to provide informed consent and comply with follow-up protocols.
- No prior history of atrial fibrillation or other significant arrhythmias.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.